| Isolated Hepatic Perfusion in Combination With Ipilimumab and Nivolumab in Patients With Uveal Melanoma Metastases (NCT04463368) | Vastra Gotaland Region | 2021-03-08 |
| TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT. (NCT04013802) | Baylor College of Medicine | 2021-03-08 |
| Neoantigen Vaccine Therapy Against H3.3-K27M Diffuse Intrinsic Pontine Glioma (NCT04749641) | Yang Zhang | 2021-03-08 |
| A Phase I Dose Escalation Study of Selinexor Plus Nivolumab and Ipilimumab in Advanced/Metastatic Solid Malignancies (NCT04850755) | National University Hospital, Singapore | 2021-03-08 |
| a Clinical Research of BCMA-Targeted Prime CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease (NCT04776330) | Chongqing Precision Biotech Co., Ltd | 2021-03-07 |
| Immunotherapy (NHS-IL12 & Bintrafusp Alfa) and Radiation Therapy for the Treatment of Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer, the REINA Trial (NCT04756505) | M.D. Anderson Cancer Center | 2021-03-07 |
| a Clinical Research of CD19 and CD22 Targeted Prime CAR-T Cell in Relapsed/Refractory B-ALL (NCT04781634) | Chongqing Precision Biotech Co., Ltd | 2021-03-07 |
| Evaluation of the Safety and Efficacy of Hemacord HPC, Cord Blood in Subjects With Acute Ischemic Stroke (NCT03735277) | BHI Therapeutic Sciences | 2021-03-06 |
| Tislelizumab Combined With Anlotinib and Chemotherapy (XELOX) in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (TALENT) (NCT04963088) | The First Affiliated Hospital with Nanjing Medical University | 2021-03-06 |
| Brain Tumor-Specific Immune Cells (IL13Ralpha2-CAR T Cells) for the Treatment of Leptomeningeal Glioblastoma, Ependymoma, or Medulloblastoma (NCT04661384) | City of Hope Medical Center | 2021-03-05 |
| Acmella Oleracea in the Analgesia of the Digital Rectal Examination (NCT05141864) | Universidade do Vale do Sapucai | 2021-03-05 |
| Low-dose Fostemsavir Extended Release Relative Bioavailability Study (NCT04757974) | ViiV Healthcare | 2021-03-05 |
| A Drug Drug Interaction (DDI) Study of Selpercatinib and Dabigatran in Healthy Participants (NCT04782076) | Loxo Oncology, Inc. | 2021-03-05 |
| Pharmacokinetic and Pharmacodynamic Study of a Novel Sublingual Aspirin Tablet (NCT04792723) | Vita Green Health Products Co. Ltd | 2021-03-05 |
| Compare Pharmacokinetics and Safety of JP-1366 Between Korean and Caucasian (NCT05181124) | Onconic Therapeutics Inc. | 2021-03-05 |
| Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells (NCT04626583) | University of Illinois at Chicago | 2021-03-05 |
| Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors (NCT04579757) | Hutchmed | 2021-03-05 |
| A First-in-Human Study of Single and Multiple Doses of Amilo-5MER in Healthy Subjects (NCT05857215) | Galmed Pharmaceuticals Ltd | 2021-03-05 |
| LTX-109 as Treatment for Hidradenitis Suppurativa (NCT04756336) | Pharma Holdings AS | 2021-03-05 |
| Skin Rejuvenation Using Stem Cell Secretome (NCT06217627) | COR clinic of Regenerative Medicine | 2021-03-05 |
| A Study of the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects (NCT05337254) | Satsuma Pharmaceuticals, Inc. | 2021-03-05 |
| Targeted Imaging of Melanoma for Alpha-Particle Radiotherapy (NCT04904120) | Perspective Therapeutics | 2021-03-05 |
| Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole (NCT04120636) | Targeted Therapy Technologies, LLC | 2021-03-05 |
| Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors. (NCT04778839) | First Affiliated Hospital of Zhejiang University | 2021-03-04 |
| TH1902 in Patients With Advanced Solid Tumors (NCT04706962) | Theratechnologies | 2021-03-04 |
| Antiseptic Irrigation for Pleural Infection (NCT04761133) | Alexandria University | 2021-03-04 |
| Bioequivalence Study of Prednisolone and Dexamethasone (NCT04733144) | University Medical Center Groningen | 2021-03-04 |
| CD19-CAR_Lenti T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and DLBCL or PML (NCT04787263) | Bambino Gesù Hospital and Research Institute | 2021-03-04 |
| Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer (NCT04703920) | University of Michigan Rogel Cancer Center | 2021-03-04 |
| A Phase 1 Study of ADI-001 in B Cell Malignancies (NCT04735471) | Adicet Therapeutics | 2021-03-04 |
| Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ST-2427 (NCT04475198) | SiteOne Therapeutics, Inc. | 2021-03-04 |
| BGB-15025 Alone and in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Participants With Advanced Solid Tumors (NCT04649385) | BeiGene | 2021-03-04 |
| A Study in Patients With Non-cystic Fibrosis Bronchiectasis to Test How Well Different Doses of BI 1323495 Are Tolerated and How BI 1323495 Affects Biomarkers of Inflammation (NCT04656275) | Boehringer Ingelheim | 2021-03-04 |
| Study to Assess the Safety, Tolerability, And Pharmacokinetics of Staccato Alprazolam in Healthy Japanese, Chinese, and Caucasian Participants (NCT04782388) | UCB Biopharma SRL | 2021-03-04 |
| Safety and Efficacy of a Lipiodol Emulsion for the Embolization of Hypervascularizations in Patients With Knee Pain (LipioJoint1) (NCT04733092) | Assistance Publique - Hôpitaux de Paris | 2021-03-03 |
| Prospective Observational Study of SynCone® Concept (NCT03957265) | Marcio Zaffalon Casati | 2021-03-03 |
| Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL) (NCT03938987) | University of Alberta | 2021-03-03 |
| Clinical Study of IBI362 in Healthy Chinese Male Subjects (NCT04773977) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-03-03 |
| A Study of Two Different Formulations of LY3209590 in Healthy Participants (NCT04768842) | Eli Lilly and Company | 2021-03-03 |
| Guselkumab (Anti-IL 23 Monoclonal Antibody) for Alcohol Associated Liver Disease (NCT04736966) | University of California, San Diego | 2021-03-03 |
| A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Healthy Participants (NCT04736134) | Bristol-Myers Squibb | 2021-03-03 |
| Beta-blockade With Landiolol in Out-of-hospital Cardiac Arrest (NCT05554978) | Medical University of Vienna | 2021-03-03 |
| A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies (NCT04678648) | RasCal Therapeutics, Inc. | 2021-03-03 |
| Berinert (C1INH) vs Placebo for DGF/IRI (NCT04696146) | Cedars-Sinai Medical Center | 2021-03-03 |
| First in Human Study of UCT-01-097 in Participants With Advanced Solid Tumors (NCT04761601) | 1200 Pharma, LLC | 2021-03-03 |
| To Evaluate the Pharmacokinetics of XNW4107 in Healthy Adult Young Females and in Healthy Adult Elderly Males and Females. (NCT04801043) | Evopoint Biosciences Inc. | 2021-03-02 |
| A Bioequivalence Study of APX001 High-load and Low-load Tablets (NCT05491733) | Basilea Pharmaceutica | 2021-03-02 |
| Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection (NCT04608812) | OncoSynergy, Inc. | 2021-03-02 |
| Drug-drug Interaction Study of CTP-543 and Itraconazole in Healthy Adult Subjects (NCT04743414) | Concert Pharmaceuticals | 2021-03-02 |
| A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma (NCT04594642) | AstraZeneca | 2021-03-02 |
| APR-246 in Combination With Acalabrutinib or Venetoclax Based Therapy in Subjects With R/R Non Hodgkin Lymphomas (NHL) (NCT04419389) | Aprea Therapeutics | 2021-03-02 |
| A Safety and Pharmacokinetic Study Between HLX02 and Herceptin®(US-licensed and EU-approved) in Healthy Chinese Male Subjects (NCT04670796) | Shanghai Henlius Biotech | 2021-03-02 |
| Comparative Study Between Combined Vaginal Misoprostol (NCT04981457) | Cairo University | 2021-03-02 |
| A Single Ascending Dose Study Of CY150112 After Single Oral Administration in Healthy Chinese Subjects (NCT04839926) | Jiangsu Nhwa Pharmaceutical Co., Ltd. | 2021-03-02 |
| Increasing Activity for Veterans With PTSD (NCT04383496) | VA Office of Research and Development | 2021-03-02 |
| COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral Platform in Healthy South African Adults (NCT04710303) | ImmunityBio, Inc. | 2021-03-02 |
| Clinical Study of Single Dose IL-6R mAb Injection in RA Patients (NCT05232396) | Beijing VDJBio Co., LTD. | 2021-03-02 |
| Bioequivalence Study of Apixaban Tablets in Healthy Chinese Subjects (NCT05841446) | The Affiliated Hospital of Qingdao University | 2021-03-02 |
| Single Dose Glumetinib in Healthy Chinese Male Subjects (NCT05507294) | Haihe Biopharma Co., Ltd. | 2021-03-02 |
| A Study on the Reactogenicity, Safety and Immune Response of a Vaccine Against Herpes Simplex Virus (HSV)-2 in Healthy Participants Aged 18-40 Years (NCT04762511) | GlaxoSmithKline | 2021-03-02 |
| Safety and Tolerability of NTX-101 in Korean Healthy Volunteers (NCT05041543) | Pinotbio, Inc. | 2021-03-02 |
| Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia Patients (NCT04836507) | Curocell Inc. | 2021-03-02 |
| RPM CD19-mbIL15-CAR-T Cells in Patient With Advanced Lymphoid Malignancies (NCT04844086) | Eden BioCell Ltd. | 2021-03-02 |
| CBD for Dental Pain (NCT04642404) | The University of Texas Health Science Center at San Antonio | 2021-03-01 |
| Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2 (NCT04846010) | All Natural Medicine Clinic, LLC | 2021-03-01 |
| Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention (NCT04555343) | Fraser Health | 2021-03-01 |
| Effect of Carbamazepine on the Pharmacokinetics (PK) of AT-527 (NCT04784000) | Atea Pharmaceuticals, Inc. | 2021-03-01 |
| Dasatinib Plus Anti-CD19/CD22 Bispecific CAR-T Cell Therapy for Elderly Ph-positive ALL Patients (NCT05523661) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2021-03-01 |
| Pre-Exposure Prophylaxis (PrEP)- Gender Affirming Hormone Therapy (GAHT) Interactions in TGW (NCT04760691) | Johns Hopkins University | 2021-03-01 |
| EFFECTS OF MOXIFLOXACIN AND GEMIFLOXACIN ON BLOOD GLUCOSE AND ECG MORPHOLOGY OF EUGLYCEMICS:A CLINICAL STUDY (NCT04692623) | Shaheed Benazir Bhutto University Sheringal Dir Upper | 2021-03-01 |
| Testing the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast Cancer (NCT04345913) | National Cancer Institute (NCI) | 2021-03-01 |
| Selinexor & Talazoparib in Advanced Refractory Solid Tumors; Advanced/Metastatic Triple Negative Breast Cancer (START) (NCT05035745) | National University Hospital, Singapore | 2021-03-01 |
| Inhibition of Sterile Inflammation by Digoxin (NCT03559868) | Yale University | 2021-03-01 |
| Tissue Distribution, Pharmacokinetics, Safety, and Tolerability After a Single Dose of TNP-2092 in Participants Undergoing Primary Total Hip or Knee Arthroplasty (NCT04294862) | TenNor Therapeutics Limited | 2021-03-01 |
| Hormonal Stimulation of Spermatogenesis (NCT05483621) | Egymedicalpedia | 2021-03-01 |
| Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast Cancer (NCT03749850) | UMC Utrecht | 2021-03-01 |
| Allogeneic γδ T Cell Therapy for the Treatment of Solid Tumors (NCT04765462) | Chinese PLA General Hospital | 2021-03-01 |
| Nigella 5 in the Treatment of SARS COV2 (COVID-19) (NCT04914767) | Hôpital Universitaire Sahloul | 2021-03-01 |
| Immunotherapy With CD19 CAR T-cells for B-Cell Lymphoma, ALL and CLL (NCT02546739) | Beijing Doing Biomedical Co., Ltd. | 2021-03-01 |
| Safety and Pharmacokinetics of Fluzoparib in Healthy Subjects and Those With Impaired Liver Function (NCT04694365) | Jiangsu HengRui Medicine Co., Ltd. | 2021-03-01 |
| NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors (NCT05131763) | Fudan University | 2021-03-01 |
| A Study of Safety and Efficacy of PET-adapted Treatment With Nivolumab at the Fixed Dose 40 mg, Ifosfamide, Carboplatin, Etoposide (NICE-40) in Patients With Relapsed/Refractory Hodgkin Lymphoma (NCT04981899) | St. Petersburg State Pavlov Medical University | 2021-03-01 |
| A Phase 1, Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalation Study in Healthy Subjects (NCT04772365) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2021-03-01 |
| Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors (NCT04952272) | Second Affiliated Hospital of Guangzhou Medical University | 2021-03-01 |
| Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy (NCT04676633) | Sirnaomics | 2021-03-01 |
| Novel Treatment for Patients With Peanut Allergy: Intralymphatic Immunotherapy (NCT04200989) | Scripps Health | 2021-03-01 |
| Sequential Radiotherapy With CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies With Extramedullary Lesions (NCT04790747) | Zhejiang University | 2021-03-01 |
| A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian Cancer (NCT03281681) | DelMar Pharmaceuticals, Inc. | 2021-03-01 |
| Study to Evaluate the Safety and Concentrations of Monoclonal Antibody Against Virus That Causes COVID-19 Disease. (NCT04932850) | Toscana Life Sciences Sviluppo s.r.l. | 2021-03-01 |
| Safety of T Regulatory Cell Therapy in Subjects With COVID-19 Induced Acute Respiratory Distress Syndrome (NCT04737161) | Stanford University | 2021-03-01 |
| Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of of HZBio1 in Healthy Subjects (NCT04765995) | Hangzhou Grand Biologic Pharmaceutical, Inc. | 2021-03-01 |
| Efficacy Of Oral Melatonin To Prevent Necrotizing Enterocolitis (NCT05033639) | Ilocos Training and Regional Medical Center | 2021-03-01 |
| CAR-T Cells for HIV Infection (NCT04648046) | Steven Deeks | 2021-03-01 |
| The Phosphodiesterase 3 Inhibitor Cilostazol as an Adjunct to Conventional Therapy in Patients With Osteoarthritis (NCT04789837) | Sadat City University | 2021-03-01 |
| Saccharomyces Cerevisiae for Irritable Bowel Syndrome (NCT05149599) | Ziauddin University | 2021-03-01 |
| Effectiveness of Patient-Controlled Intravenous Analgesia (PCIA) With Fentanyl (NCT05429567) | Egymedicalpedia | 2021-03-01 |
| Immunotherapy With Bispecific CAR-T Cells for B-Cell Lymphoma, ALL and CLL (NCT03271515) | Beijing Doing Biomedical Co., Ltd. | 2021-03-01 |
| Donor-derived CAR-T Cells in the Treatment of AML Patients (NCT04766840) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2021-03-01 |
| Safety and Efficacy of Human Umbilical Cord Blood Plasma Infusion for Age-Related Cognitive Decline (NCT04566757) | American Academy of Regenerative Medicine | 2021-03-01 |
| Safety and Immunogenicity of an Intranasal SARS-CoV-2 Vaccine (BBV154) for COVID-19 (NCT04751682) | Bharat Biotech International Limited | 2021-03-01 |